Download the case study
.png?width=1200&height=1400&name=EU%20TDS_GSK_CS%201-2-3%20(2).png)
Supporting pharmaceutical leaders like GSKDownload the case study
.png?width=3000&height=3000&name=LP%20CS%201-2-3%20(1).png)
As GSK continues to expand its R&D capabilities across Europe and advance its environmental sustainability commitments, reliable water treatment partnerships become increasingly critical. This case study demonstrates how a long-term partnership approach can support facility growth, maintain regulatory compliance, and achieve ambitious sustainability targets without compromising operational excellence.
A leading multinational pharmaceutical company operates a critical research and development facility in the UK, requiring ultra-pure water quality across multiple applications for formulation and laboratory testing of new medicines. As the facility expanded over two decades, the company needed a reliable, long-term water treatment partner capable of delivering consistent pharmaceutical-grade water for process applications, equipment cleaning, laboratory use, and utility water for boilers. The site also required solutions to improve energy efficiency, reduce water consumption, and minimise operational disruption during system upgrades and maintenance while meeting evolving sustainability goals.
For over 20 years, Veolia has enabled the manufacturer to focus on R&D while we handle their complete water treatment needs. Our partnership approach means minimal disruption during expansions and upgrades, with rapid response maintenance to keep operations running smoothly. We've supported every phase of the site's growth, adapting our solutions as requirements evolved and sustainability goals advanced.
Fill the form to discover how this pharmaceutical R&D facility achieved 20+ years of consistent pharmaceutical-grade water quality.
.png?width=1200&height=1400&name=EU%20TDS_GSK_CS%201-2-3%20(2).png)